Drug Database · Clinicians

Interferon alfa-2b

Brands (1) ReliferonShow all

Immunostimulant PH FDA category

Rx · Prescription drug1 PH productPNF-listedVAT-exempt
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Solution for injection: 3 million IU/0.5 mL

Registered products in the Philippines

1 product registered with the Food and Drug Administration (FDA) Philippines list Interferon alfa-2b as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Interferon alfa-2b
Package insert
ReliferonInterferon Alfa-2b
3 million IU/0.5 mL Solution for Injection (IM/SC)Single dose. Type I glass vial x 0.5 mL (Box of 1's).
RxVAT-exempt
Reliance Life Sciences Pvt. Ltd. (Plant II)India
Ambica International Corporation
BRP-050
Nov 21, 2028

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Formulary and coverage

Philippine National FormularyListed as Interferon Alfa 2B (human)
PNF listingInj.: 3 million IU and 5 million IU per mL vial + diluent (IM, SC)Restrictions: Specific expertise, diagnostic precision, or special equipment required for proper use (PNF code 1); Limited indications or narrow spectrum of activity (PNF code 2)
PhilHealth GAMOTNo

Sources:

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  2. PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .